NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a global movement is preparing to shift the spotlight from the ubiquitous pink ribbons of early detection toward a more sobering and urgent reality. On October 13, 2026, designated as National Metastatic Breast Cancer Awareness Day, more than 325 landmarks across the globe will illuminate in the symbolic colors of teal, green, and pink. This coordinated display, known as #LightUpMBC, serves as a beacon for the estimated hundreds of thousands of individuals living with metastatic breast cancer (MBC)—a disease for which there is currently no cure.
The campaign, organized by METAvivor Research and Support, aims to bridge the gap between awareness and action. While the "pink" movement has successfully promoted mammograms and early intervention, the MBC community often feels sidelined by a narrative that focuses primarily on "beating" cancer. #LightUpMBC seeks to reclaim the conversation, raising vital funds for the research necessary to transform Stage 4 breast cancer from a terminal diagnosis into a manageable, chronic condition.
Main Facts: A Global Beacon for the MBC Community
The #LightUpMBC campaign is a multifaceted initiative that combines architectural illumination, digital storytelling, and high-level fundraising. In 2026, the scale of the event has reached unprecedented heights, involving over 195 cities across 20 countries and all 50 U.S. states.
The Significance of the Colors
While pink is the universal symbol for breast cancer, the #LightUpMBC campaign utilizes a specific tri-color palette:
- Teal: Representing healing and spirituality.
- Green: Symbolizing the triumph of spring over winter, renewal, and life.
- Pink: Acknowledging the breast cancer origin of the disease.
Together, these colors represent the unique journey of the metastatic patient—one that is defined not by a "finish line" of being cancer-free, but by a continuous cycle of treatment, hope, and resilience.
The Scale of Participation
The 2026 roster of participating landmarks includes some of the most recognizable structures in the world. From the One World Trade Center in New York City and the Willis Tower in Chicago to the Philadelphia City Hall and the international border’s Niagara Falls, the visual impact is designed to be inescapable. Internationally, the movement has gained significant traction, with the Ness Bridge in Scotland and the Mactan-Cebu Airport in the Philippines joining the cause.
The Digital Centerpiece: #LightUpMBC Live
Complementing the physical illuminations is #LightUpMBC Live, a virtual broadcast streaming at 8 p.m. ET / 5 p.m. PT. Hosted by creator Tami Eagle Bowling and Broadway star Kara Lindsay, the program serves as a global town hall for the MBC community. It features a blend of scientific discourse, patient testimonials, and world-class musical performances, all aimed at educating the public and soliciting donations that go directly toward Stage 4 research.
Chronology: From a Single Bridge to a Global Phenomenon
The evolution of #LightUpMBC is a testament to the power of grassroots advocacy and the legacy of those lost to the disease.
The Inspiration (2017)
The campaign’s roots trace back to Jessica Moore, a young woman diagnosed with MBC who recognized the disparity in funding and attention given to Stage 4 patients. Her simple wish was to see a local landmark lit in MBC awareness colors to validate the experiences of those living with the terminal form of the disease. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up for MBC.
The Foundation of a Movement (2018–2022)
Following Moore’s passing at the age of 36, her best friend, Laura Inahara, took up the mantle. What began as a local tribute quickly resonated with patients and families across the United States. By partnering with METAvivor, the campaign gained a structural backbone, allowing it to scale from a handful of bridges to dozens of city halls and skyscrapers. During these years, the campaign introduced the #LightUpMBC Live stream, ensuring that even those too ill to travel could participate in the movement from their homes.
Global Expansion and Record Funding (2023–2026)
By 2026, the campaign has evolved into a sophisticated global operation. It has successfully raised over $2.7 million for METAvivor-funded research to date. The current year marks the largest participation in the event’s history, reflecting a growing international recognition that metastatic research is the "final frontier" in the fight against breast cancer.
Supporting Data: The Urgent Math of Metastasis
The necessity of the #LightUpMBC campaign is underscored by harrowing statistics provided by the National Cancer Institute and the American Cancer Society.
Mortality and Diagnosis
In 2026, an estimated 42,670 people in the United States alone are expected to die from breast cancer. This averages out to approximately 117 deaths every single day. Crucially, 100% of these deaths are the result of metastasis—when the cancer spreads from the breast to vital organs such as the bones, liver, lungs, or brain.
The data reveals two primary pathways to an MBC diagnosis:
- De Novo Diagnosis: Approximately 6% of new breast cancer cases are metastatic at the time of initial diagnosis.
- Recurrence: A significant percentage of patients originally diagnosed with early-stage (Stage 1-3) breast cancer will see their disease return as Stage 4 months, years, or even decades after completing their initial "curative" treatment.
The Funding Disparity
Historically, only a small fraction of breast cancer research funding (estimated between 2% and 5%) has been dedicated specifically to metastatic disease. The vast majority of resources are directed toward prevention, early detection, and primary treatment. METAvivor remains the only U.S. organization that dedicated 100% of its net proceeds exclusively to Stage 4 research, filling a critical void in the scientific landscape.
Official Responses: Voices from the Frontlines
The leaders of the movement emphasize that while the lights are beautiful, the underlying message is one of survival and scientific necessity.
Dr. Kelly Shanahan, METAvivor Board President, who has lived with MBC since 2013, highlights the life-extending power of research. "When I was diagnosed… I certainly didn’t think I’d still be here 13 years later," she stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, Founder of #LightUpMBC, reflected on the emotional weight of the campaign’s growth. "Jessica [Moore] hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love… and has now raised over $2.7 million for critical MBC research."
Tami Eagle Bowling, Campaign Director and MBC patient of 11 years, noted the importance of the live broadcast. "We are bringing the stories of patients directly from these illuminated landmarks into people’s living rooms. It’s about making the invisible, visible."
Implications: Redefining the "Pink" Narrative
The success of #LightUpMBC carries significant implications for the future of oncology and patient advocacy.
Challenging "Pinkwashing"
The campaign serves as a critical counter-narrative to "pinkwashing"—the corporate use of pink ribbons to sell products without contributing meaningfully to the lives of those dying from the disease. By focusing on the "darker" side of breast cancer, #LightUpMBC forces a public reckoning with the fact that awareness of mammograms is not the same as a cure for Stage 4.
The Shift to Chronic Disease Management
The ultimate goal of METAvivor-funded research is to move MBC from a terminal death sentence to a chronic condition, similar to HIV or Type 1 Diabetes. As research uncovers new targeted therapies, immunotherapies, and ways to combat treatment resistance, the "survivable" window for MBC patients is slowly expanding. The funds raised on October 13 are directly responsible for the clinical trials that make this extension of life possible.
Community and Mental Health
Beyond the science, the campaign addresses the profound isolation felt by MBC patients. In a culture that celebrates "survivors" who have finished treatment, those in "forever treatment" often feel forgotten. The global illumination provides a visual confirmation that they are seen and supported by a worldwide network.
A Call to Action
As the sun sets on October 13, 2026, and landmarks from New York to Cebu glow in teal, green, and pink, the message is clear: awareness is the starting point, but research is the only exit strategy. The public is encouraged to participate by photographing their local landmarks, sharing them on social media with the hashtag #LightUpMBC, and contributing to the research fund that may one day turn the lights out on metastatic breast cancer for good.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization. It is the only organization in the US that exclusively funds Stage 4 metastatic breast cancer research. 100% of all donations go directly to MBC research grants.
About #LightUpMBC:
LightUpMBC is a global landmark campaign and annual live-streamed event dedicated to raising awareness and research funds for metastatic breast cancer. For more information, to view the list of participating landmarks, or to donate, visit www.lightupmbc.org.
About the Author
